Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Antithrombotic Therapy Effects on Coagulation in Healthy Males
NCT01812200Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran, rivaroxaban in Atrial fibrillation (AFib), acute coronary syndrome (ACS), sponsored by Medical University of Vienna. Started Oct 2012; status: completed.
02
Drugs
dabigatranrivaroxaban
03
Conditions
Atrial fibrillation (AFib)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01812200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812200.